New paradigms in cervical cancer prevention: opportunities and risks View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-12-17

AUTHORS

Guglielmo Ronco, Paolo Giorgi Rossi

ABSTRACT

Testing for the DNA of high-risk types of papilloma virus (HPV) is more sensitive than cytology in detecting pre-cancerous lesions. One of the main advantages will be the possibility of applying prolonged screening intervals. However adequate screening protocols (age of start and stop, screening intervals, management of HPV positive women) need to be applied in order to avoid over-referral to colposcopy and over-treatment and to maintain sustainable costs. Further follow-up of running trials and research on molecular markers will better define these parameters. The new situation will require organised screening programmes with rigorous protocols and monitoring. This will be even more needed when women vaccinated for HPV 16 and 18 will be screened. Research on how to best screen vaccinated women is a priority. This paper proposes an overview of the plausible impact of new technologies in cervical cancer screening in the near future and in the vaccinated cohorts. More... »

PAGES

23

References to SciGraph publications

  • 2008-01-08. HPV and cervical cancer: screening or vaccination? in BRITISH JOURNAL OF CANCER
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/1472-6874-8-23

    DOI

    http://dx.doi.org/10.1186/1472-6874-8-23

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1044937668

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/19091066


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Public Health and Health Services", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Age Factors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cervical Intraepithelial Neoplasia", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Colposcopy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA, Viral", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Early Detection of Cancer", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Forecasting", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Health Services Needs and Demand", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Human papillomavirus 16", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Human papillomavirus 18", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mass Screening", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Papillomavirus Infections", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Patient Selection", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Practice Guidelines as Topic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Primary Prevention", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Referral and Consultation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Sensitivity and Specificity", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Uterine Cervical Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Vaccination", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Vaginal Smears", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Unit\u00e0 di Epidemiologia dei Tumori, CPO Piemonte, Torino, Italy", 
              "id": "http://www.grid.ac/institutes/grid.420240.0", 
              "name": [
                "Unit\u00e0 di Epidemiologia dei Tumori, CPO Piemonte, Torino, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ronco", 
            "givenName": "Guglielmo", 
            "id": "sg:person.01206540103.18", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206540103.18"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laziosanit\u00e0 \u2013 Agenzia di Sanit\u00e0 Pubblica, Regione Lazio, Roma, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Laziosanit\u00e0 \u2013 Agenzia di Sanit\u00e0 Pubblica, Regione Lazio, Roma, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Giorgi Rossi", 
            "givenName": "Paolo", 
            "id": "sg:person.0673212370.59", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673212370.59"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/sj.bjc.6604146", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006772600", 
              "https://doi.org/10.1038/sj.bjc.6604146"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2008-12-17", 
        "datePublishedReg": "2008-12-17", 
        "description": "Testing for the DNA of high-risk types of papilloma virus (HPV) is more sensitive than cytology in detecting pre-cancerous lesions. One of the main advantages will be the possibility of applying prolonged screening intervals. However adequate screening protocols (age of start and stop, screening intervals, management of HPV positive women) need to be applied in order to avoid over-referral to colposcopy and over-treatment and to maintain sustainable costs. Further follow-up of running trials and research on molecular markers will better define these parameters. The new situation will require organised screening programmes with rigorous protocols and monitoring. This will be even more needed when women vaccinated for HPV 16 and 18 will be screened. Research on how to best screen vaccinated women is a priority. This paper proposes an overview of the plausible impact of new technologies in cervical cancer screening in the near future and in the vaccinated cohorts.", 
        "genre": "article", 
        "id": "sg:pub.10.1186/1472-6874-8-23", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1028438", 
            "issn": [
              "1472-6874"
            ], 
            "name": "BMC Women's Health", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "8"
          }
        ], 
        "keywords": [
          "cervical cancer prevention", 
          "high-risk types", 
          "pre-cancerous lesions", 
          "vaccinated cohort", 
          "screening interval", 
          "cervical cancer", 
          "HPV 16", 
          "papilloma virus", 
          "cancer prevention", 
          "screening protocol", 
          "better screen", 
          "women", 
          "rigorous protocol", 
          "colposcopy", 
          "referral", 
          "lesions", 
          "cohort", 
          "cytology", 
          "cancer", 
          "trials", 
          "prevention", 
          "molecular markers", 
          "virus", 
          "treatment", 
          "risk", 
          "markers", 
          "protocol", 
          "sustainable cost", 
          "interval", 
          "near future", 
          "monitoring", 
          "screen", 
          "program", 
          "DNA", 
          "plausible impact", 
          "research", 
          "types", 
          "impact", 
          "priority", 
          "new paradigm", 
          "overview", 
          "possibility", 
          "new technologies", 
          "paradigm", 
          "future", 
          "opportunities", 
          "situation", 
          "cost", 
          "parameters", 
          "advantages", 
          "order", 
          "new situation", 
          "main advantage", 
          "technology", 
          "paper"
        ], 
        "name": "New paradigms in cervical cancer prevention: opportunities and risks", 
        "pagination": "23", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1044937668"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/1472-6874-8-23"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "19091066"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/1472-6874-8-23", 
          "https://app.dimensions.ai/details/publication/pub.1044937668"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-09-02T15:52", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_461.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/1472-6874-8-23"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1472-6874-8-23'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1472-6874-8-23'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1472-6874-8-23'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1472-6874-8-23'


     

    This table displays all metadata directly associated to this object as RDF triples.

    213 TRIPLES      21 PREDICATES      102 URIs      93 LITERALS      28 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/1472-6874-8-23 schema:about N0c5a7690a6f0427b9310469383ee49c2
    2 N106eca1bd5c541de90db8559bf0b13b8
    3 N107b55e1948941bfb1dfe5b328459a23
    4 N1ed7a277d00147cca250110e2cefa6b5
    5 N2cdc81678a9c465c8c9509ec5d2cfafd
    6 N357c499e1cbc4d218a999defe452a7b5
    7 N388d1031046e428f8d326d9ed41b95d4
    8 N3e554bee169b496c913533c8bdede85d
    9 N44b23e6a276d4cf78e6c576993a0ef8c
    10 N4bb59ee4c4ee4d47bc0e9cc55868b478
    11 N801ea27895fc4b88b9b15b468d10eef0
    12 N85b1cfcffcbe48c68422ae153846ab11
    13 N92858efa9289439480f36965dacec936
    14 N95c8292c99b440a3840f18ddaef882b5
    15 N9c8a0aa4acf24e7ead9d6278b716972e
    16 Nb32b05067da34e7ab8beda0b311eb0a8
    17 Nba7cd6e411a54d76866258fc897a5ac2
    18 Nd9cfc49045ee43258442d4223e237f9e
    19 Nefc84685c4974d21add6a4ee9dbcea99
    20 Nf2c7c609e5ac491a94f25696023bce44
    21 Nf85cacba29a244baad498f240a56aa8f
    22 anzsrc-for:11
    23 anzsrc-for:1117
    24 schema:author Na86c8cd480f24bb8bf2047a4b6796e9f
    25 schema:citation sg:pub.10.1038/sj.bjc.6604146
    26 schema:datePublished 2008-12-17
    27 schema:datePublishedReg 2008-12-17
    28 schema:description Testing for the DNA of high-risk types of papilloma virus (HPV) is more sensitive than cytology in detecting pre-cancerous lesions. One of the main advantages will be the possibility of applying prolonged screening intervals. However adequate screening protocols (age of start and stop, screening intervals, management of HPV positive women) need to be applied in order to avoid over-referral to colposcopy and over-treatment and to maintain sustainable costs. Further follow-up of running trials and research on molecular markers will better define these parameters. The new situation will require organised screening programmes with rigorous protocols and monitoring. This will be even more needed when women vaccinated for HPV 16 and 18 will be screened. Research on how to best screen vaccinated women is a priority. This paper proposes an overview of the plausible impact of new technologies in cervical cancer screening in the near future and in the vaccinated cohorts.
    29 schema:genre article
    30 schema:isAccessibleForFree true
    31 schema:isPartOf N58ace032ced2417c94e271da3694b01a
    32 Ne44c0039174f4fcab509ddfc6b810417
    33 sg:journal.1028438
    34 schema:keywords DNA
    35 HPV 16
    36 advantages
    37 better screen
    38 cancer
    39 cancer prevention
    40 cervical cancer
    41 cervical cancer prevention
    42 cohort
    43 colposcopy
    44 cost
    45 cytology
    46 future
    47 high-risk types
    48 impact
    49 interval
    50 lesions
    51 main advantage
    52 markers
    53 molecular markers
    54 monitoring
    55 near future
    56 new paradigm
    57 new situation
    58 new technologies
    59 opportunities
    60 order
    61 overview
    62 paper
    63 papilloma virus
    64 paradigm
    65 parameters
    66 plausible impact
    67 possibility
    68 pre-cancerous lesions
    69 prevention
    70 priority
    71 program
    72 protocol
    73 referral
    74 research
    75 rigorous protocol
    76 risk
    77 screen
    78 screening interval
    79 screening protocol
    80 situation
    81 sustainable cost
    82 technology
    83 treatment
    84 trials
    85 types
    86 vaccinated cohort
    87 virus
    88 women
    89 schema:name New paradigms in cervical cancer prevention: opportunities and risks
    90 schema:pagination 23
    91 schema:productId N03aa037828c64d7f89a55471214549fb
    92 N22866a1de4d9495d91fd0df712959a7f
    93 Ne0477221c37a4f1c83cc27fbca519c9c
    94 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044937668
    95 https://doi.org/10.1186/1472-6874-8-23
    96 schema:sdDatePublished 2022-09-02T15:52
    97 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    98 schema:sdPublisher Nb850ccb00a8b4b86a741ab56fe5eefb9
    99 schema:url https://doi.org/10.1186/1472-6874-8-23
    100 sgo:license sg:explorer/license/
    101 sgo:sdDataset articles
    102 rdf:type schema:ScholarlyArticle
    103 N03aa037828c64d7f89a55471214549fb schema:name doi
    104 schema:value 10.1186/1472-6874-8-23
    105 rdf:type schema:PropertyValue
    106 N0c5a7690a6f0427b9310469383ee49c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    107 schema:name Mass Screening
    108 rdf:type schema:DefinedTerm
    109 N106eca1bd5c541de90db8559bf0b13b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    110 schema:name Human papillomavirus 18
    111 rdf:type schema:DefinedTerm
    112 N107b55e1948941bfb1dfe5b328459a23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    113 schema:name Vaccination
    114 rdf:type schema:DefinedTerm
    115 N1ed7a277d00147cca250110e2cefa6b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    116 schema:name Forecasting
    117 rdf:type schema:DefinedTerm
    118 N22866a1de4d9495d91fd0df712959a7f schema:name dimensions_id
    119 schema:value pub.1044937668
    120 rdf:type schema:PropertyValue
    121 N2cdc81678a9c465c8c9509ec5d2cfafd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Practice Guidelines as Topic
    123 rdf:type schema:DefinedTerm
    124 N357c499e1cbc4d218a999defe452a7b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    125 schema:name Patient Selection
    126 rdf:type schema:DefinedTerm
    127 N388d1031046e428f8d326d9ed41b95d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    128 schema:name Uterine Cervical Neoplasms
    129 rdf:type schema:DefinedTerm
    130 N3e554bee169b496c913533c8bdede85d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name DNA, Viral
    132 rdf:type schema:DefinedTerm
    133 N44b23e6a276d4cf78e6c576993a0ef8c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    134 schema:name Sensitivity and Specificity
    135 rdf:type schema:DefinedTerm
    136 N4bb59ee4c4ee4d47bc0e9cc55868b478 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Papillomavirus Infections
    138 rdf:type schema:DefinedTerm
    139 N58ace032ced2417c94e271da3694b01a schema:issueNumber 1
    140 rdf:type schema:PublicationIssue
    141 N801ea27895fc4b88b9b15b468d10eef0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Colposcopy
    143 rdf:type schema:DefinedTerm
    144 N85b1cfcffcbe48c68422ae153846ab11 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Primary Prevention
    146 rdf:type schema:DefinedTerm
    147 N92858efa9289439480f36965dacec936 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Referral and Consultation
    149 rdf:type schema:DefinedTerm
    150 N95c8292c99b440a3840f18ddaef882b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Vaginal Smears
    152 rdf:type schema:DefinedTerm
    153 N9c8a0aa4acf24e7ead9d6278b716972e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name Humans
    155 rdf:type schema:DefinedTerm
    156 Na86c8cd480f24bb8bf2047a4b6796e9f rdf:first sg:person.01206540103.18
    157 rdf:rest Nf227c1b3a4d648f89dbe471dbc9c408c
    158 Nb32b05067da34e7ab8beda0b311eb0a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    159 schema:name Human papillomavirus 16
    160 rdf:type schema:DefinedTerm
    161 Nb850ccb00a8b4b86a741ab56fe5eefb9 schema:name Springer Nature - SN SciGraph project
    162 rdf:type schema:Organization
    163 Nba7cd6e411a54d76866258fc897a5ac2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    164 schema:name Female
    165 rdf:type schema:DefinedTerm
    166 Nd9cfc49045ee43258442d4223e237f9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    167 schema:name Age Factors
    168 rdf:type schema:DefinedTerm
    169 Ne0477221c37a4f1c83cc27fbca519c9c schema:name pubmed_id
    170 schema:value 19091066
    171 rdf:type schema:PropertyValue
    172 Ne44c0039174f4fcab509ddfc6b810417 schema:volumeNumber 8
    173 rdf:type schema:PublicationVolume
    174 Nefc84685c4974d21add6a4ee9dbcea99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    175 schema:name Cervical Intraepithelial Neoplasia
    176 rdf:type schema:DefinedTerm
    177 Nf227c1b3a4d648f89dbe471dbc9c408c rdf:first sg:person.0673212370.59
    178 rdf:rest rdf:nil
    179 Nf2c7c609e5ac491a94f25696023bce44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    180 schema:name Early Detection of Cancer
    181 rdf:type schema:DefinedTerm
    182 Nf85cacba29a244baad498f240a56aa8f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    183 schema:name Health Services Needs and Demand
    184 rdf:type schema:DefinedTerm
    185 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    186 schema:name Medical and Health Sciences
    187 rdf:type schema:DefinedTerm
    188 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
    189 schema:name Public Health and Health Services
    190 rdf:type schema:DefinedTerm
    191 sg:journal.1028438 schema:issn 1472-6874
    192 schema:name BMC Women's Health
    193 schema:publisher Springer Nature
    194 rdf:type schema:Periodical
    195 sg:person.01206540103.18 schema:affiliation grid-institutes:grid.420240.0
    196 schema:familyName Ronco
    197 schema:givenName Guglielmo
    198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206540103.18
    199 rdf:type schema:Person
    200 sg:person.0673212370.59 schema:affiliation grid-institutes:None
    201 schema:familyName Giorgi Rossi
    202 schema:givenName Paolo
    203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673212370.59
    204 rdf:type schema:Person
    205 sg:pub.10.1038/sj.bjc.6604146 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006772600
    206 https://doi.org/10.1038/sj.bjc.6604146
    207 rdf:type schema:CreativeWork
    208 grid-institutes:None schema:alternateName Laziosanità – Agenzia di Sanità Pubblica, Regione Lazio, Roma, Italy
    209 schema:name Laziosanità – Agenzia di Sanità Pubblica, Regione Lazio, Roma, Italy
    210 rdf:type schema:Organization
    211 grid-institutes:grid.420240.0 schema:alternateName Unità di Epidemiologia dei Tumori, CPO Piemonte, Torino, Italy
    212 schema:name Unità di Epidemiologia dei Tumori, CPO Piemonte, Torino, Italy
    213 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...